GeneDx Holdings Corp
NASDAQ:WGS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
GeneDx Holdings Corp
NASDAQ:WGS
|
US |
|
W
|
Woori Technology Investment Co Ltd
KOSDAQ:041190
|
KR |
|
Micreed Co Ltd
TSE:7687
|
JP |
|
A
|
Australian Critical Minerals Ltd
ASX:ACM
|
AU |
|
Mapfre SA
OTC:MPFRY
|
ES |
|
S
|
Semperit Holding AG
VSE:SEM
|
AT |
|
Northern Graphite Corp
XTSX:NGC
|
CA |
|
E
|
Epicon Bhd
KLSE:EPICON
|
MY |
|
C
|
Changhae Ethanol Co Ltd
KOSDAQ:004650
|
KR |
|
Lucara Diamond Corp
TSX:LUC
|
CA |
|
F
|
Fonciere Inea SA
PAR:INEA
|
FR |
|
Comsys Holdings Corp
OTC:CMSYF
|
JP |
Wall Street
Price Targets
WGS Price Targets Summary
GeneDx Holdings Corp
According to Wall Street analysts, the average 1-year price target for
WGS
is 159.8 USD
with a low forecast of 131.3 USD and a high forecast of 185.85 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is WGS's stock price target?
Price Target
159.8
USD
According to Wall Street analysts, the average 1-year price target for
WGS
is 159.8 USD
with a low forecast of 131.3 USD and a high forecast of 185.85 USD.
What is GeneDx Holdings Corp's Revenue forecast?
Projected CAGR
26%
For the last 6 years the
compound annual growth rate for
GeneDx Holdings Corp's revenue is
14%.
The projected
CAGR
for the next 3 years is
26%.